Ceryx Medical Raises $15M to Revolutionise Heart Failure Treatment

Archived press release, published Jun 2025. Reproduced as issued; it reflects the company’s position at the time.

We’ve just secured $15 million in new funding to accelerate the development of our next-generation, biomimetic pacemaker—designed to work in harmony with the body’s natural rhythms. Backed by promising clinical results and leading investors, we’re one step closer to transforming care for millions living with heart failure.

← All news